订阅小程序
旧版功能

Cell Division Cycle 37 Change after Bortezomib-Based Induction Therapy Helps to Predict Clinical Response and Prognosis in Multiple Myeloma Patients.

HEMATOLOGY(2023)

引用 0|浏览14
关键词
Multiple myeloma,bortezomib-based induction treatment,cell division cycle 37,longitudinal change,response and survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要